Matsuo, Hidemasa http://orcid.org/0000-0002-7578-006X
Imamura, Akari
Shimizu, Madoka
Inagaki, Maiko
Tsuji, Yuko
Nakabo, Shuichiro
Hashimoto, Motomu
Ito, Hiromu
Tanaka, Shiro
Mimori, Tsuneyo
Fujii, Yasutomo
Funding for this research was provided by:
JSPS KAKENHI (18K12103)
Article History
Received: 10 June 2019
Accepted: 3 September 2019
First Online: 25 September 2019
Compliance with ethical standards
:
: M.H., H.I., and T.M. belong to a department that is financially supported by four pharmaceutical companies (Tanabe-Mitsubishi, Chugai, UCB Japan, and Ayumi). M.H. receives research grants and/or speaker honoraria from Astellas, Tanabe-Mitsubishi, Eisai, and Bristol-Meyers. H.I. receives research grants and/or speaker fee from BMS, Astellas, Asahi-Kasei, and Kyocera Medical. The KURAMA cohort study is supported by a grant from Daiichi-Sankyo. The present study is conducted as an investigator-initiated study. These companies have no role in the design of the study, the collection or analysis of the data, the writing of the manuscript, or the decision to submit the manuscript for publication. H.M., A.I., M.S., M.I., Y.T., S.N., S.T., and Y.F. have no competing financial interests to declare.
: The study was conducted in accordance with the principles set down in the Declaration of Helsinki and was approved by the ethics committee of Kyoto University (R0357). All patients provided written informed consent.